Aug 26 (Reuters) - Japan suspended the use of 1.63 million doses of Moderna Inc's (MRNA.O) COVID-19 vaccine on Thursday, more than a week after the domestic distributor received reports of contaminants in some vials.

Moderna: Moderna confirms having been notified of cases of particulate matter being seen in drug product vials of its COVID-19 vaccine. The company is investigating the reports and remains committed to working expeditiously with its partner, Takeda, and regulators to address this.